The Contribution of <i>JAK2</i> 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms

Haplotype 46/1 (GGCC) consists of a set of genetic variations distributed along chromosome 9p.24.1, which extend from the Janus Kinase 2 gene to Insulin like <i>4</i>. Marked by four jointly inherited variants (rs3780367, rs10974944, rs12343867, and rs1159782), this haplotype has a stron...

Full description

Bibliographic Details
Main Authors: Jhemerson Paes, George A. V. Silva, Andréa M. Tarragô, Lucivana P. de Souza Mourão
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/20/12582
_version_ 1797472683790696448
author Jhemerson Paes
George A. V. Silva
Andréa M. Tarragô
Lucivana P. de Souza Mourão
author_facet Jhemerson Paes
George A. V. Silva
Andréa M. Tarragô
Lucivana P. de Souza Mourão
author_sort Jhemerson Paes
collection DOAJ
description Haplotype 46/1 (GGCC) consists of a set of genetic variations distributed along chromosome 9p.24.1, which extend from the Janus Kinase 2 gene to Insulin like <i>4</i>. Marked by four jointly inherited variants (rs3780367, rs10974944, rs12343867, and rs1159782), this haplotype has a strong association with the development of <i>BCR-ABL1</i>-negative myeloproliferative neoplasms (MPNs) because it precedes the acquisition of the JAK2V617F variant, a common genetic alteration in individuals with these hematological malignancies. It is also described as one of the factors that increases the risk of familial MPNs by more than five times, 46/1 is associated with events related to inflammatory dysregulation, splenomegaly, splanchnic vein thrombosis, Budd–Chiari syndrome, increases in RBC count, platelets, leukocytes, hematocrit, and hemoglobin, which are characteristic of MPNs, as well as other findings that are still being elucidated and which are of great interest for the etiopathological understanding of these hematological neoplasms. Considering these factors, the present review aims to describe the main findings and discussions involving the 46/1 haplotype, and highlights the molecular and immunological aspects and their relevance as a tool for clinical practice and investigation of familial cases.
first_indexed 2024-03-09T20:04:43Z
format Article
id doaj.art-55cd549ab465456f978910c064f2feb8
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T20:04:43Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-55cd549ab465456f978910c064f2feb82023-11-24T00:33:52ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-10-0123201258210.3390/ijms232012582The Contribution of <i>JAK2</i> 46/1 Haplotype in the Predisposition to Myeloproliferative NeoplasmsJhemerson Paes0George A. V. Silva1Andréa M. Tarragô2Lucivana P. de Souza Mourão3Programa de Pós-Graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas (UEA), Manaus 69850-000, AM, BrazilPrograma de Pós-Graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas (UEA), Manaus 69850-000, AM, BrazilPrograma de Pós-Graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas (UEA), Manaus 69850-000, AM, BrazilPrograma de Pós-Graduação em Ciências Aplicadas à Hematologia, Universidade do Estado do Amazonas (UEA), Manaus 69850-000, AM, BrazilHaplotype 46/1 (GGCC) consists of a set of genetic variations distributed along chromosome 9p.24.1, which extend from the Janus Kinase 2 gene to Insulin like <i>4</i>. Marked by four jointly inherited variants (rs3780367, rs10974944, rs12343867, and rs1159782), this haplotype has a strong association with the development of <i>BCR-ABL1</i>-negative myeloproliferative neoplasms (MPNs) because it precedes the acquisition of the JAK2V617F variant, a common genetic alteration in individuals with these hematological malignancies. It is also described as one of the factors that increases the risk of familial MPNs by more than five times, 46/1 is associated with events related to inflammatory dysregulation, splenomegaly, splanchnic vein thrombosis, Budd–Chiari syndrome, increases in RBC count, platelets, leukocytes, hematocrit, and hemoglobin, which are characteristic of MPNs, as well as other findings that are still being elucidated and which are of great interest for the etiopathological understanding of these hematological neoplasms. Considering these factors, the present review aims to describe the main findings and discussions involving the 46/1 haplotype, and highlights the molecular and immunological aspects and their relevance as a tool for clinical practice and investigation of familial cases.https://www.mdpi.com/1422-0067/23/20/12582JAK2 germline haplotypemyeloid neoplasmshaplotypemolecular pathogenesissingle nucleotide polymorphisms
spellingShingle Jhemerson Paes
George A. V. Silva
Andréa M. Tarragô
Lucivana P. de Souza Mourão
The Contribution of <i>JAK2</i> 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
International Journal of Molecular Sciences
JAK2 germline haplotype
myeloid neoplasms
haplotype
molecular pathogenesis
single nucleotide polymorphisms
title The Contribution of <i>JAK2</i> 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
title_full The Contribution of <i>JAK2</i> 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
title_fullStr The Contribution of <i>JAK2</i> 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
title_full_unstemmed The Contribution of <i>JAK2</i> 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
title_short The Contribution of <i>JAK2</i> 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
title_sort contribution of i jak2 i 46 1 haplotype in the predisposition to myeloproliferative neoplasms
topic JAK2 germline haplotype
myeloid neoplasms
haplotype
molecular pathogenesis
single nucleotide polymorphisms
url https://www.mdpi.com/1422-0067/23/20/12582
work_keys_str_mv AT jhemersonpaes thecontributionofijak2i461haplotypeinthepredispositiontomyeloproliferativeneoplasms
AT georgeavsilva thecontributionofijak2i461haplotypeinthepredispositiontomyeloproliferativeneoplasms
AT andreamtarrago thecontributionofijak2i461haplotypeinthepredispositiontomyeloproliferativeneoplasms
AT lucivanapdesouzamourao thecontributionofijak2i461haplotypeinthepredispositiontomyeloproliferativeneoplasms
AT jhemersonpaes contributionofijak2i461haplotypeinthepredispositiontomyeloproliferativeneoplasms
AT georgeavsilva contributionofijak2i461haplotypeinthepredispositiontomyeloproliferativeneoplasms
AT andreamtarrago contributionofijak2i461haplotypeinthepredispositiontomyeloproliferativeneoplasms
AT lucivanapdesouzamourao contributionofijak2i461haplotypeinthepredispositiontomyeloproliferativeneoplasms